Anne Le Bouter
Impact in
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- SARS-CoV-2 and COVID-19 Research 4
- Antimicrobial Resistance in Staphylococcus 2
- COVID-19 Clinical Research Studies 2
- Antifungal resistance and susceptibility 1
- Co-authors
- Slim Fourati (4 shared papers)Roland Leclercq (1 shared paper)Vincent Cattoir (1 shared paper)Sébastien Maury (2 shared papers)Rabah Redjoul (2 shared papers)Elsken van der Wall (1 shared paper)Petra van der Groep (1 shared paper)Fred H. Menko (1 shared paper)
- Journals
- Journal of Clinical Pathology (1 paper)Clinical Microbiology and Infection (1 paper)Ophthalmology (1 paper)Journal of Hematology & Oncology (1 paper)The Lancet Haematology (1 paper)
- Partner nations
- FranceNetherlandsUnited States
In The Last Decade
Anne Le Bouter
8 papers receiving 187 citations
Peers
Comparison fields: 5 of 46
- Infectious Diseases 101
- Molecular Medicine 13
- Oncology 52
- Cancer Research 25
- Clinical Biochemistry 11
Countries citing papers authored by Anne Le Bouter
This map shows the geographic impact of Anne Le Bouter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Le Bouter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Le Bouter more than expected).
Fields of papers citing papers by Anne Le Bouter
This network shows the impact of papers produced by Anne Le Bouter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Le Bouter. The network helps show where Anne Le Bouter may publish in the future.
Co-authors
The 25 scholars most cited alongside Anne Le Bouter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 67 | |
| 2 | 2021 | 49 | |
| 3 | 2010 | 33 | |
| 4 | 2012 | 15 | |
| 5 | 2022 | 10 | |
| 6 | 2022 | 10 | |
| 7 | 2021 | 7 | |
| 8 | 2011 | 1 |
About Anne Le Bouter
Anne Le Bouter is a scholar working on Infectious Diseases, Ophthalmology, Oncology, Epidemiology and Obstetrics and Gynecology, having authored 8 papers that have together received 192 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), Antimicrobial Resistance in Staphylococcus (2 papers), COVID-19 Clinical Research Studies (2 papers), Ocular Surface and Contact Lens (1 paper), Antifungal resistance and susceptibility (1 paper), COVID-19 Impact on Reproduction (1 paper), Plant Pathogenic Bacteria Studies (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Infectious Diseases (101 citations), Molecular Medicine (13 citations), Oncology (52 citations), Cancer Research (25 citations) and Clinical Biochemistry (11 citations). Anne Le Bouter has collaborated with scholars based in France, Netherlands and United States. Frequent co-authors include Slim Fourati, Roland Leclercq, Vincent Cattoir, Sébastien Maury, Rabah Redjoul, Elsken van der Wall, Petra van der Groep, Fred H. Menko, Ivar Siccama and René H.M. Verheijen. Their work appears in journals such as Journal of Clinical Pathology, Clinical Microbiology and Infection, Ophthalmology, Journal of Hematology & Oncology and The Lancet Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.